Navigation Links
Vessix to Present V2 Renal Denervation System™ for Hypertension at LINC 2012
Date:1/19/2012

LAGUNA HILLS, Calif., Jan. 18, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today that the first public presentation of its new percutaneous V2 Renal Denervation System™ for the treatment of medication-resistant hypertension will be made at LINC 2012 in Leipzig, Germany on Thursday, January 26, 2012. 

Renal denervation is a new percutaneous catheter-based technique for the treatment of medication resistant or uncontrolled hypertension. The new V2 Renal Denervation System is designed to be faster, easier to deploy and less invasive for the patient than the alternatives available today in the market.

The presentation, titled "Radiofrequency balloon-mediated renal denervation: The V2 Catheter by Vessix Vascular," will be made by Prof. med. Horst Sievert during a session for new emerging technologies for renal denervation chaired by Krishna Rocha-Singh, M.D.

Dr. Sievert, a globally recognized interventional cardiologist based in Frankfurt, Germany, is a key opinion leader in the field of renal denervation. 

Vessix's new device, the V2 System for the treatment of medication-resistant hypertension, is an over-the-wire, balloon catheter with electrodes and thermistors mounted on the exterior of the balloon to facilitate the delivery of RF energy to the nerves surrounding the renal artery. Vessix will begin its first-in-man clinical study next month.

Key benefits of the Vessix approach to renal denervation include:

  • Therapy is delivered via a balloon catheter that is quite familiar to interventional cardiologists and other physicians, thereby increasing the usability and safety profile of the device.
  • Ability to deliver RF treatment in as little as thirty (30) seconds per artery, which is significantly faster than the only other competitively marketed renal denervation system that takes 20-30 minutes to deliver treatment to each renal artery.
  • Rapid RF treatment time greatly increases the efficiency of the procedure, significantly reduces discomfort for the patient and provides the benefits of lower exposure to radiation, lower amount of contrast dye and, therefore, lower renal toxicity to the patient.
  •  

    About Vessix Vascular, Inc. – Vessix, initially founded in 2003 as Minnow Medical, Inc. is a privately-held pre-revenue stage company developing novel radiofrequency balloon catheter technology. The Company's initial product, the ZCath® System, has a CE Mark for use in reducing plaque in peripheral leg arteries. For more information on Vessix Vascular, please visit the Company's website at www.vessixvascular.com or contact Matt Clawson at Allen & Caron Inc at 949-474-4300 or via email at matt@allencaron.com.Contact:

    Matt Clawson or 

    Len Hall (Media)  

    Allen & Caron Inc  

    949-474-4300  

    matt@allencaron.com 

    len@allencaron.com


    '/>"/>
    SOURCE Vessix Vascular, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Vessix Vascular Completes $23 Million Financing
    2. Intellect Neurosciences, Inc. to Present at BIO Asia International Conference
    3. Palatin Technologies to Present at BOCEMb, Noble Financial Capital Markets Eighth Annual Equity Conference
    4. Bacterin to Present at the Noble 8th Annual Equity Conference on January 17, 2012
    5. MiMedx Group, Inc. to Present at the Noble Capital Markets 8th Annual Equity Conference
    6. Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI): Phase III Data on Bayers Investigational Compound Regorafenib (BAY 73-4506) in Patients with Metastatic Colorectal Cancer to be Presented as Late Breaking Or
    7. Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation
    8. Ultra Clean to Present at the 14th Annual Needham Growth Conference
    9. nContacts Cardiac Ablation Technology to be Presented in Two Noteworthy Posters at Boston Atrial Fibrillation Symposium 2012
    10. WuXi PharmaTech Provides Update of 2011 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
    11. Ambit Biosciences to Present at 30th Annual J.P. Morgan Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/27/2016)... TURIN, Italy , April 27, 2016 ... MR-guided linear accelerator (MR-linac) platform will be the focal ... annual meeting of the European Society for Radiotherapy & ... Elekta,s MR-linac integrates a state-of-the-art radiotherapy system and ... a physician to clearly see the patient,s anatomy in ...
    (Date:4/27/2016)... April 27, 2016   Zillion Group ... health technology platform, which specializes in live video ... scalable digital products, Zillion enables companies to realize ... consumers to take control of their health. ... conferencing – including one-to-one, group and webcast scheduled ...
    (Date:4/27/2016)... , April 27, 2016  Bayer Animal Health ... senior from the University of Florida College of ... Bayer Excellence in Communication Award (BECA). Brittany was ... were awarded a total of $70,000 in scholarship ... four years, Bayer has provided a total of ...
    Breaking Medicine Technology:
    (Date:5/2/2016)... ... ... “Engineering Bubbles,” an oil painting submitted by Canadian radiology resident Dr. Kari ... the Annual Meeting in Los Angeles. The first annual art forum was a platform ... attendees. , “Through art I hope to educate people about radiology and its ...
    (Date:5/2/2016)... ... ... Over $60 Billion is spent annually on products for our favorite furry ... site for Toys, Tots, Pets & More (TTPM) announced the 15 winners of the ... Metropolitan Pavilion in New York City. , Chosen from a field of hundreds of ...
    (Date:5/2/2016)... ... May 02, 2016 , ... ... new Specialty Pharmacy Patient Satisfaction Award that will recognize specialty pharmacies for their ... from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout 2016. Results ...
    (Date:5/2/2016)... , ... May 02, 2016 , ... According to an ... one in four girls are sexually abused before the age of 18. Of those ... to tell her story and others. , In her new book, Lyah! Lyah! ...
    (Date:5/2/2016)... ... May 02, 2016 , ... Consultative health care market research ... Callandrillo and Duane Reed, VP of business development of AJMC Strategic Solutions, will ... Group (PBIRG) General Meeting from May 15-17 at the Boca Raton Resort ...
    Breaking Medicine News(10 mins):